Announcements Trials

Browse Landscape

Phase

Status

Recruiting 5 Active not recruiting 3 Terminated 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 16 Neoplasms 14 Breast Neoplasms 11 Melanoma 10 Lung Neoplasms 8 Colorectal Neoplasms 8 Prostatic Neoplasms 7 Neoplasm Metastasis 7 Multiple Myeloma 7 Pancreatic Neoplasms 6 Ovarian Neoplasms 6 Lymphoma, Large B-Cell, Diffuse 6 Leukemia, Myeloid, Acute 6 Lymphoma, Non-Hodgkin 5 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 5 Hodgkin Disease 5 Brain Neoplasms 5 Uterine Cervical Neoplasms 4 Triple Negative Breast Neoplasms 4 Squamous Cell Carcinoma of Head and Neck 4 Recurrence 4 Rectal Neoplasms 4 Hematologic Neoplasms 4 Glioblastoma 4 Endometrial Neoplasms 4 Urinary Bladder Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Myelodysplastic Syndromes 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma 3

Interventions

fezolinetant 1 Specimen Handling 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma, Intraductal, Noninfiltrating × 30 days × Clear all

NCT06617455 2026-05-06

VEnT

University of Michigan Rogel Cancer Center

Phase 2 Terminated

Carcinoma, Intraductal, Noninfiltrating

Data powered by HemOnc (CC BY 4.0) Colophon ⚡